Literature DB >> 12014783

National trends in the use of psychotropic medications by children.

Mark Olfson1, Steven C Marcus, Myrna M Weissman, Peter S Jensen.   

Abstract

OBJECTIVES: Little information exists on national trends in the use of psychotropic medication by children and adolescents. The objective of this report is to compare patterns and predictors of psychotropic medication use by children and adolescents in the United States in 1987 and 1996.
METHOD: An analysis of medication use data is presented from two nationally representative surveys of the general population focusing on children 18 years of age and younger who used one or more prescribed psychotropic medication during the survey years. Rates of stimulant, antidepressant, and other psychotropic medication use are reported.
RESULTS: The overall annual rate of psychotropic medication use by children increased from 1.4 per 100 persons in 1987 to 3.9 in 1996 (p < .0001). Significant increases were found in the rate of stimulant use (0.6 per 100 persons to 2.4 per 100 persons), antidepressant use (0.3 per 100 persons to 1.0 per 100 persons), other psychotropic medications (0.6 per 100 persons to 1.2 per 100 persons), and coprescription of different classes of psychotropic medications (0.03 per 100 persons to 0.23 per 100 persons), especially antidepressants and stimulants. Rates of antipsychotic and benzodiazepine use remained stable. In 1996, stimulant use was especially common in children aged 6 to 14 years (4.1 per 100), and antidepressant use was common in children aged 15 to 18 years (2.1 per 100 persons).
CONCLUSION: Between 1987 and 1996, there was a marked expansion in use of psychotropic medications by children, especially stimulants and antidepressants.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12014783     DOI: 10.1097/00004583-200205000-00008

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  81 in total

1.  Using Best-Worst Scaling to Measure Caregiver Preferences for Managing their Child's ADHD: A Pilot Study.

Authors:  Susan dosReis; Xinyi Ng; Emily Frosch; Gloria Reeves; Charles Cunningham; John F P Bridges
Journal:  Patient       Date:  2015-10       Impact factor: 3.883

2.  Time trends in symptoms of mental illness in children and adolescents in Canada.

Authors:  Seanna E McMartin; Mila Kingsbury; Jennifer Dykxhoorn; Ian Colman
Journal:  CMAJ       Date:  2014-11-03       Impact factor: 8.262

3.  A critique of the international consensus statement on ADHD.

Authors:  Sami Timimi; Joanna Moncrieff; Jon Jureidini; Jonathan Leo; David Cohen; Charles Whitfield; Duncan Double; Jonathan Bindman; Henry Andrews; Eia Asen; Pat Bracken; Barry Duncan; Michaele Dunlap; Galves Albert; Michael Green; Tom Greening; Janice Hill; Rhodri Huws; Bertram Karon; Brian Kean; Michael McCubbin; Begum Miatra; Loren Mosher; Sue Parry; S DuBose Ravenel; Dominick Riccio; Richard Shulman; Jeanne Stolzer; Phil Thomas; Graham Vimpani; Al Wadsworth; Dave Walker; Norbert Wetzel; Rupert White
Journal:  Clin Child Fam Psychol Rev       Date:  2004-03

4.  Pediatric psychotropic polypharmacy.

Authors:  Mark R Zonfrillo; Joseph V Penn; Henrietta L Leonard
Journal:  Psychiatry (Edgmont)       Date:  2005-08

5.  Chronic methylphenidate treatment during early life is associated with greater ethanol intake in socially isolated rats.

Authors:  Kathryn E Gill; Ann M Chappell; Thomas J R Beveridge; Linda J Porrino; Jeffrey L Weiner
Journal:  Alcohol Clin Exp Res       Date:  2014-08       Impact factor: 3.455

6.  Child/Adolescent anxiety multimodal study: evaluating safety.

Authors:  Moira A Rynn; John T Walkup; Scott N Compton; Dara J Sakolsky; Joel T Sherrill; Sa Shen; Philip C Kendall; James McCracken; Anne Marie Albano; John Piacentini; Mark A Riddle; Courtney Keeton; Bruce Waslick; Allan Chrisman; Satish Iyengar; John S March; Boris Birmaher
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2014-12-31       Impact factor: 8.829

7.  The selective serotonin reuptake inhibitors controversy in the treatment of depression in children.

Authors:  Elizabeth B Weller; Sheridan Tucker; Ronald A Weller
Journal:  Curr Psychiatry Rep       Date:  2005-04       Impact factor: 5.285

8.  Child and adolescent psychiatrists' reported monitoring behaviors for second-generation antipsychotics.

Authors:  Angie Mae Rodday; Susan K Parsons; Catherine Mankiw; Christoph U Correll; Adelaide S Robb; Bonnie T Zima; Tully S Saunders; Laurel K Leslie
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-04-28       Impact factor: 2.576

9.  Adolescent experience of psychotropic treatment.

Authors:  Jerry Floersch; Lisa Townsend; Jeffrey Longhofer; Michelle Munson; Victoria Winbush; Derrick Kranke; Rachel Faber; Jeremy Thomas; Janis H Jenkins; Robert L Findling
Journal:  Transcult Psychiatry       Date:  2009-03

10.  The Preschool Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS) 6-year follow-up.

Authors:  Mark A Riddle; Kseniya Yershova; Deborah Lazzaretto; Natalya Paykina; Gayane Yenokyan; Laurence Greenhill; Howard Abikoff; Benedetto Vitiello; Tim Wigal; James T McCracken; Scott H Kollins; Desiree W Murray; Sharon Wigal; Elizabeth Kastelic; James J McGough; Susan dosReis; Audrey Bauzó-Rosario; Annamarie Stehli; Kelly Posner
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2013-02-08       Impact factor: 8.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.